Track the 싸이토젠 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 싸이토젠 has published 71 reports. The latest transaction was filed on 26 June 2026 (Sale). Among the most active insiders: 정윤영. All data is accessible without an account.
71
Insider Decl.
n/a
Thresholds
n/a
28 ops.
Buy Volume
n/a
7 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
싸이토젠 is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the diagnosis and treatment of diseases.